ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesD04.20

D04.20

Billable

Carcinoma in situ of skin of unspecified ear and external auricular canal

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 D04.20 is a billable code used to indicate a diagnosis of carcinoma in situ of skin of unspecified ear and external auricular canal.

Key Diagnostic Point:

Carcinoma in situ (CIS) of the skin of the ear and external auricular canal is a non-invasive form of skin cancer characterized by the abnormal growth of cells in the epidermis. This condition is often asymptomatic and may present as a scaly patch, a non-healing sore, or a change in skin color. CIS is considered a precursor to invasive squamous cell carcinoma (SCC) and is typically diagnosed through a biopsy. The risk factors for developing CIS include prolonged sun exposure, fair skin, and a history of skin cancer. Surveillance protocols often involve regular dermatological examinations to monitor for changes in the lesion or the development of new lesions. Early detection and treatment are crucial to prevent progression to invasive cancer, which can lead to more severe health complications. Treatment options may include surgical excision, cryotherapy, or topical chemotherapy, depending on the size and location of the lesion. Patients diagnosed with CIS should be educated about sun protection and skin self-examinations to facilitate early detection of any new or changing lesions.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Variability in clinical presentation and documentation
  • Need for precise anatomical location identification
  • Differentiation from other skin lesions
  • Potential for progression to invasive carcinoma

Audit Risk Factors

  • Inadequate documentation of clinical findings
  • Failure to document follow-up care
  • Misclassification of the lesion type
  • Lack of clear treatment plans

Specialty Focus

Medical Specialties

Dermatology

Documentation Requirements

Detailed descriptions of the lesion, biopsy results, and treatment plans.

Common Clinical Scenarios

Diagnosis of CIS during routine skin checks, management of lesions post-biopsy.

Billing Considerations

Ensure clear documentation of the lesion's characteristics and any changes over time.

Oncology

Documentation Requirements

Comprehensive treatment plans, including surgical and non-surgical options.

Common Clinical Scenarios

Referral for surgical intervention or monitoring of CIS lesions.

Billing Considerations

Document the rationale for treatment choices and patient education on skin cancer risks.

Coding Guidelines

Inclusion Criteria

Use D04.20 When
  • Follow the official ICD
  • CM coding guidelines, ensuring accurate documentation of the diagnosis, treatment, and follow
  • up care
  • Include specific details about the lesion's location and characteristics to support the use of D04

Exclusion Criteria

Do NOT use D04.20 When
No specific exclusions found.

Related ICD-10 Codes

Related CPT Codes

11100CPT Code

Biopsy of skin, excisional

Clinical Scenario

Used when a biopsy is performed to confirm CIS diagnosis.

Documentation Requirements

Document the site, size, and type of biopsy performed.

Specialty Considerations

Dermatologists should ensure accurate coding based on the biopsy technique used.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of conditions like carcinoma in situ, improving the accuracy of data collection and reimbursement processes. D04.20 provides specificity that was not available in ICD-9, enhancing clinical documentation and care management.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of conditions like carcinoma in situ, improving the accuracy of data collection and reimbursement processes. D04.20 provides specificity that was not available in ICD-9, enhancing clinical documentation and care management.

Reimbursement & Billing Impact

reimbursement processes. D04.20 provides specificity that was not available in ICD-9, enhancing clinical documentation and care management.

Resources

Clinical References

  • •
    American Academy of Dermatology

Coding & Billing References

  • •
    American Academy of Dermatology

Frequently Asked Questions

What is carcinoma in situ?

Carcinoma in situ is a non-invasive form of cancer where abnormal cells are present but have not invaded surrounding tissues. It is often considered a precursor to invasive cancer.